AbbVie, Inc. (ABBV)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about AbbVie, Inc. (ABBV)
Go deeper and ask any question about ABBV
Company Performance
Current Price
as of Sep 13, 2024$194.21
P/E Ratio
64.96
Market Cap
$343.04B
Description
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Metrics
Overview
- HQNorth Chicago, IL
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerABBV
- Price$194.21+0.10%
Trading Information
- Market Cap$343.04B
- Float99.91%
- Average Daily Volume (1m)4,241,085
- Average Daily Volume (3m)5,246,000
- EPS$3.00
Company
- Revenue$55.00B
- Rev Growth (1yr)4.31%
- Net Income$1.36B
- Gross Margin71.01%
- EBITDA Margin48.94%
- EBITDA$7.08B
- EV$361.28B
- EV/Revenue6.57
- P/E64.96
- P/S6.25